Par Pharmaceutical Companies - M&A Summary, Ownership, and Business Overview

Life ScienceCompany

Par Pharmaceutical Companies M&A Summary

Par Pharmaceutical Companies has acquired 2 companies of its own. A total of 2 acquisitions came from private equity firms. It has also divested 1 asset.

Par Pharmaceutical Companies’ largest acquisition to date was in 2014, when it acquired JHP Pharmaceuticals for $490M. Par Pharmaceutical Companies has acquired in 2 different US states. The Company’s most targeted sectors include healthcare services (50%) and life science (50%).

Par Pharmaceutical Companies Ownership

Who owns Par Pharmaceutical Companies?

Par Pharmaceutical Companies is owned by Endo International. It was acquired on May 18, 2015.

Was Par Pharmaceutical Companies formerly PE-backed?

Yes. Par Pharmaceutical Companies was formerly owned by 1 private investor.

Par Pharmaceutical Companies Business Overview

Where is Par Pharmaceutical Companies headquartered?

Par Pharmaceutical Companies is headquartered in Woodcliff Lake, New Jersey.

How many employees does Par Pharmaceutical Companies have?

Par Pharmaceutical Companies has 978 employees.

What sector is Par Pharmaceutical Companies in?

Par Pharmaceutical Companies is a life science company.

When was Par Pharmaceutical Companies founded?

Par Pharmaceutical Companies was founded in 1978.

M&A Summary

  • M&A Total Activity3
    • M&A Buy Activity2
    • M&A Sell Activity1
  • Total Sectors Invested 2
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 3
  • M&A Advisors 1

Par Pharmaceutical Companies, Inc.

300 Tice Boulevard,
Woodcliff Lake, New Jersey 07677
United States,
(201) 802-4000
www.parpharm.com

Par Pharma specializes in developing, licensing, manufacturing, marketing and distributing generic drugs.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 2 - - - - - 2
vol $490M $490M
Sell (0.0/yr) # 1 - - - - - 1
  3

Most Recent M&A

Company Date Value Type
JHP Pharmaceuticals LLC 2014-01-21 490M USD Add-on Acquisition
Parsippany, New Jersey · www.jhppharma.com
Par Pharmaceutical Co., Inc. - Research and Development Capabilities 2009-10-22 - Divestiture
, United States
QOL Medical LLC 2009-03-01 - Add-on Acquisition
Vero Beach, Florida · www.qolmed.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (50%) - 1 (100%) -
Healthcare Services 1 (50%) 490M (100%) - -
Total 2 $490M 1 -

By Geo

State/Country Buy Value Sell Value
United States 2 490M 1 -
  New Jersey 1 490M - -
  Florida 1 - - -
Total 2 $490M 1 -

Top M&A Advisors

Legal Deals
Ropes & Gray
1

Deal Values

buy # Total
$100M to $1B 1 $490M
TOTAL $490M
Largest JHP Pharmaceuticals LLC
$490M (2014-01-21)

M&A Connections

Deals
Acquired from
Investor(s)
100%
2 (100%)
Divested to
Strategic(s)
100%
1 (100%)

 Subscribe to unlock this and 209,130
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.